Definium Therapeutics Inc. Common Shares vs SK Hynix — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.05 (market cap $4.59B), while SK Hynix trades at $169.7 (market cap $891.31B). The key difference: SK Hynix is far larger — about 194.2× Definium Therapeutics Inc. Common Shares's market cap, and SK Hynix pays a 0.06% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and SK Hynix for 10 Days on average.
| DFTX | SKHY | |
|---|---|---|
Market Cap | $4.59B | $891.31B |
Volume | 2,103,937 | 22,268,296 |
Sector | Health | Technology |
52-Week High | $48.45 | $198.63 |
52-Week Low | $10.68 | $126.79 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $3.55B | $841.45B |
Dividend Yield | — | 0.06% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.
Read more on SKHY →